Radiosensitizing Favors Response to Peptide Receptor Radionuclide Therapy in Patients With Highly Proliferative Neuroendocrine Malignancies Preliminary Evidence From a Clinical Pilot Study

DSpace Repository

Radiosensitizing Favors Response to Peptide Receptor Radionuclide Therapy in Patients With Highly Proliferative Neuroendocrine Malignancies Preliminary Evidence From a Clinical Pilot Study

Author: Trautwein, Nils Florian; Hinterleitner, Clemens; Kiefer, Lena Sophie; Singer, Stephan; Mattern, Sven; Schwenck, Johannes; Reischl, Gerald; Sipos, Bence; Lauer, Ulrich M.; Dittmann, Helmut; Zender, Lars; la Fougere, Christian; Hinterleitner, Martina
Tübinger Autor(en):
Trautwein, Nils Florian
Hinterleitner, Clemens
Kiefer, Lena Sophie
Singer, Stephan
Mattern, Sven
Reischl, Gerald
Sipos, Bence
Dittmann, Helmut
Zender, Lars
Hinterleitner, Martina
Schwenck, Johannes Walter
Lauer, Ulrich Manfred
La Fougère, Christian Jean
Published in: Clinical Nuclear Medicine (2024), Bd. 49, H. 3, S. 207-214
Verlagsangabe: Philadelphia : Lippincott Williams & Wilkins
Language: English
Full text: http://dx.doi.org/10.1097/RLU.0000000000005006
ISSN: 0363-9762
DDC Classifikation: 610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)